Class 4 caution in use-Ponlimsi (Denosumab) 60mg Solution for Injection in Pre-filled Syringe

Teva UK Limited is reporting a labelling error on the carton for Ponlimsi (Denosumab) 60mg Solution for injection in Pre-filled Syringe. The carton states “For application to the skin” when the product is licensed for subcutaneous use.

MHRA drug alert Date: 4/6/26

MHRA drug alert link:Class 4 Medicines Defect Notification: Teva UK Ltd, Ponlimsi (Denosumab) 60mg Solution for Injection in Pre-filled Syringe, EL(26)A/27 - GOV.UK

This is a caution in use only we are not accepting stock returns

Further Information

For all medical information enquiries and information on this product, please email medinfo@tevauk.com

For stock control enquiries please email Customer.services@tevauk.com